Bristol-Myers Squibb (BMY) Stock Price
$48.28 0.9%
to add to portfolio
AI Score
-
Alternative
3 -
Fundamental
4 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Bristol-Myers Squibb, AI stock picks, stock alerts and much more.
BMY AI Stock Analysis
AI stock analysis for BMY is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Bristol-Myers Squibb (BMY) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Bristol-Myers Squibb (BMY) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Bristol-Myers Squibb (BMY), currently trading at $48.28, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BMY
-
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide.
-
Symbol
BMY
-
Market
NYSE
-
Industry
Drug Manufacturers - General
-
Market Cap
98.3B
Similar Stocks
 |
Johnson & Johnson JNJ |
$155.2 1.1% |
5 |
 |
Eli Lilly and Company LLY |
$737.7 2.1% |
7 |
 |
Pfizer PFE |
$23.49 0.2% |
4 |
 |
AbbVie ABBV |
$186.1 0.3% |
6 |
 |
Merck & Company MRK |
$76.84 0.6% |
5 |
News
BMY Alternative Data
Web Traffic
Bristol-Myers Squibb receives an estimated 806655 monthly visitors to bms.com.
-
Web Traffic
806655
-
Change from Previous Month
3.7%
-
3 Month Change
16.4%
-
YoY Change
16.4%
Twitter Followers
Bristol-Myers Squibb has 152,847 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.5% over the last month.
-
Twitter Followers
152847
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
0.9%
-
YoY Change
0.9%
Facebook Engagement
Bristol-Myers Squibb has engaged 3,996 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
3996
-
Daily Change
12.8%
-
1 Month Change
3.4%
-
3 Month Change
127.3%
-
YoY Change
127.3%
Instagram Followers
Bristol-Myers Squibb has 0 Instagram Followers on its main Instagram account.
-
Instagram Followers
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Youtube Subscribers
Bristol-Myers Squibb has 3,870 subscribers on its main Youtube channel, up by 0.8% over the last month.
-
Youtube Subscribers
3870
-
Daily Change
0%
-
1 Month Change
0.8%
-
3 Month Change
1.6%
-
YoY Change
1.6%
LinkedIn Followers
1,609,361 are following Bristol-Myers Squibb on LinkedIn, up by 1.1% over the last month.
-
LinkedIn Followers
1609361
-
Daily Change
0%
-
1 Month Change
1.1%
-
3 Month Change
3.3%
Job Postings
Bristol-Myers Squibb currenly has an estimated 1,000 open job postings, up by 56% over the last month.
-
Job Postings
1000
-
Daily Change
0%
-
1 Month Change
56%
-
3 Month Change
83.8%
-
YoY Change
83.8%
LinkedIn Employees
According to LinkedIn, Bristol-Myers Squibb has 38,507 employees, down by -0.2% over the last month.
-
LinkedIn Employees
38507
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Reddit Mentions
Bristol-Myers Squibb has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
Business Outlook
According to employee reviews, the business outlook among employees at Bristol-Myers Squibb is 43 out of 100 (neutral), down by -4.4% over the last month.
-
Business Outlook
43
-
Change from Previous Month
4.4%
-
3 Month Change
8.5%
-
YoY Change
8.5%
News Mentions
Bristol-Myers Squibb was mentioned 24 times in the news yesterday.
-
News Mentions
24
-
Daily Change
84.6%
-
1 Month Change
0%
-
3 Month Change
2300%
BMY Financials
BMY Key Metrics
-
Total Revenue
$11.2B
-
Net Income
$2.5B
-
Earnings per Share
$1.21
-
Free cash flow
$1.7B
-
EBITDA
$4.5B
-
EBITDA Ratio
0.401036
-
Total Assets
$92.4B
BMY 2-year Revenue & Income
BMY 2-year Free Cash Flow
BMY Technicals
BMY SMA
BMY RSI
FAQ
What's the current price of Bristol-Myers Squibb (BMY) Stock?
The price of an Bristol-Myers Squibb (BMY) share is $48.28.
What's the market cap of Bristol-Myers Squibb?
The current market cap of Bristol-Myers Squibb is 98.3B.
Should I buy or sell BMY?
Bristol-Myers Squibb shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Bristol-Myers Squibb is better viewed as a hold or accumulate position while waiting for further developments.
Is Bristol-Myers Squibb a good investment?
The current analysis of Bristol-Myers Squibb's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Bristol-Myers Squibb's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Bristol-Myers Squibb (BMY) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Bristol-Myers Squibb stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Bristol-Myers Squibb (BMY) that investors often compare it to?
Bristol-Myers Squibb (BMY) is often compared to similar stocks such as Johnson & Johnson, Eli Lilly and Company, Pfizer, AbbVie and Merck & Company.
What is the forecast for Bristol-Myers Squibb's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Bristol-Myers Squibb's stock price to be around $45.55 in 2026. Starting from the current price of $48.28, this represents a 5.7% change in price, indicating a bearish outlook for the stock.
How to buy Bristol-Myers Squibb (BMY) Stock?
Bristol-Myers Squibb stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Bristol-Myers Squibb shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.